Secondary Cytoreductive Surgery in Endometrial Cancer with Francesco Fanfani
Nov 25, 2024 - 33:36
Radio and PodcastLive Radio & PodcastsIn this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Anuja Jhingran to discuss the role of chemotherapy following chemoradiation after radical hysterectomy. Dr. Anuja Jhingran is a Prof...
Role of Chemotherapy following Chemoradiation After Radical Hysterectomy with Dr. Anuja Jhingran is an episode from IJGC Podcast by BMJ Group. In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Anuja Jhi...
This episode belongs to IJGC Podcast.
Use the player on this page to stream the episode online.
Published Sep 23, 2024, 16:18 long, audio available.
In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Anuja Jhingran to discuss the role of chemotherapy following chemoradiation after radical hysterectomy. Dr. Anuja Jhingran is a Professor of Radiation Oncology specializing in gynecologic cancers. Her clinical focus includes advanced ovarian, cervical, and endometrial cancers, utilizing advanced radiation techniques to reduce toxicity. Dr. Jhingran is actively involved in research with the Radiation Therapy Oncology Group (RTOG) and Gynecologic Oncology Group (GOG), serving as the national Principal Investigator for several studies. She is passionate about women's health and works internationally to improve healthcare in developing countries. Highlights: This study assessed the impact of adding adjuvant chemotherapy to chemoradiotherapy (CRT) in patients with high-risk early-stage cervical cancer post-radical hysterectomy. A total of 212 patients were analyzed, with 109 receiving CRT alone and 103 receiving CRT plus chemotherapy. The 4-year disease-free survival (DFS) was 76% for the CRT group and 77% for the CRT plus chemotherapy group (HR = 1.05, 90% CI: 0.65-1.68, p = 0.56). Overall survival (OS) rates at 4 years were 87% for CRT and 89% for the CRT plus chemotherapy arm (HR = 0.91, 90% CI: 0.49-1.69, p = 0.40). The addition of chemotherapy did not significantly improve DFS or OS.
You can listen to Role of Chemotherapy following Chemoradiation After Radical Hysterectomy with Dr. Anuja Jhingran online on Radio and Podcast. Open the player on this page to stream the available audio.
Role of Chemotherapy following Chemoradiation After Radical Hysterectomy with Dr. Anuja Jhingran is an episode from IJGC Podcast by BMJ Group.
This episode is 16:18 long.
This episode was published on Sep 23, 2024.
Yes. Use the heart button on the episode page to add it to your favorite episodes list.
Yes. This page shows related episodes from IJGC Podcast when more episodes are available from the podcast feed.
You can listen to Role of Chemotherapy following Chemoradiation After Radical Hysterectomy with Dr. Anuja Jhingran on this page when the episode audio is available from the podcast feed.
Role of Chemotherapy following Chemoradiation After Radical Hysterectomy with Dr. Anuja Jhingran is from IJGC Podcast by BMJ Group.
Published Sep 23, 2024 and 16:18 long